Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum.

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Food systems, nutrition, health and the environment
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised,
Patterns of mortality by occupation in the UK, 1991–2011: a comparative analysis of linked census and mortality records  Dr Srinivasa Vittal Katikireddi,
Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa  Prof Tonya Renee Thurman,
Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in.
The commercial determinants of health
Helen Cox, Mark P Nicol  The Lancet Infectious Diseases 
The impact of megacities on health: preparing for a resilient future
Infections related to totally implantable venous-access ports
DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection  Dr Mihály Sulyok,
Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum.
Volume 390, Issue 10092, Pages (July 2017)
Mental health indicators associated with oil spill response and clean-up: cross-sectional analysis of the GuLF STUDY cohort  Richard K Kwok, PhD, John.
Charity begins at home in global health research funding
Threats to human health by great ocean garbage patches
The predicament of patients with suspected Ebola
Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial 
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax.
Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study  Dr R McGready,
When less is more: how many doses of PCV are enough?
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants:
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study 
Do air quality alerts benefit public health? New evidence from Canada
Nicola Low, Joost H Smid  The Lancet Public Health 
Volume 392, Issue 10147, Pages (August 2018)
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study 
DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection  Dr Mihály Sulyok,
Volume 390, Issue 10092, Pages (July 2017)
Effective cross-sector collaborations create sustainability
AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised,
The effect of explosive remnants of war on global public health: a systematic mixed- studies review using narrative synthesis  Alexandra Frost, MSc, Prof.
Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled.
Arnaud Chiolero  The Lancet Public Health 
Jonathan Broad, Matthew D Snape  The Lancet Public Health 
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised,
Volume 4, Issue 6, Pages (June 2017)
Food systems, nutrition, health and the environment
Sherif M Abdalla, Robert Bortolussi, Noni E MacDonald 
Volume 389, Issue 10065, Pages (January 2017)
Patterns of mortality by occupation in the UK, 1991–2011: a comparative analysis of linked census and mortality records  Dr Srinivasa Vittal Katikireddi,
Measuring health and economic wellbeing in the Sustainable Development Goals era: development of a poverty-free life expectancy metric and estimates for.
Exposure to improved nutrition from conception to age 2 years and adult cardiometabolic disease risk: a modelling study  Nicole D Ford, PhD, Jere R Behrman,
Genes expressed in red cells could shape a malaria attack
Person-centred maternity care in low-income and middle-income countries: analysis of data from Kenya, Ghana, and India  Patience A Afulani, PhD, Beth.
Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa  Prof Tonya Renee Thurman,
Volume 393, Issue 10172, Pages (February 2019)
Elder abuse prevalence in community settings: a systematic review and meta-analysis  Yongjie Yon, MA, Christopher R Mikton, PhD, Zachary D Gassoumis, PhD,
Oral doxycycline for the prevention of postoperative trachomatous trichiasis in Ethiopia: a randomised, double-blind, placebo-controlled trial  Esmael.
Muh Geot Wong, Vlado Perkovic  The Lancet Diabetes & Endocrinology 
Thank you to our diverse (but not diverse enough) reviewers
Volume 392, Issue 10160, Pages (November 2018)
Global burden of maternal and congenital syphilis in 2008 and 2012: a health systems modelling study  N Saman Wijesooriya, MPH, Roger W Rochat, MD, Mary.
Volume 4, Issue 5, Pages (May 2017)
Artefenomel: a promising new antimalarial drug
Volume 6, Issue 3, Pages (March 2019)
Matthieu J Guitton  The Lancet Planetary Health 
Infections related to totally implantable venous-access ports
Spatial lifecourse epidemiology
Effect of a behaviour change intervention on the quality of peri-urban sanitation in Lusaka, Zambia: a randomised controlled trial  James B Tidwell, PhD,
Task sharing with non-physician health-care workers for management of blood pressure in low-income and middle-income countries: a systematic review and.
Integrating an early childhood development programme into Bangladeshi primary health-care services: an open-label, cluster-randomised controlled trial 
Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15  Prof Peter Lloyd-Sherlock,
Improving management of neonatal infections
Jeffrey T Howard, Alexis R Santos-Lozada  The Lancet Planetary Health 
Deriving a practical framework for the evaluation of health apps
Refining treatment choices for ADHD
Volume 6, Issue 7, Pages (July 2019)
Institutional challenges to achieving health equity in Ecuador
Sickle cell disease: a new era
Presentation transcript:

Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study  Alejandro Llanos-Cuentas, PhD, Martin Casapia, MPH, Raúl Chuquiyauri, PhD, Juan-Carlos Hinojosa, MD, Nicola Kerr, MA, Maria Rosario, PhD, Stephen Toovey, MD, Robert H Arch, PhD, Margaret A Phillips, PhD, Felix D Rozenberg, BA, Jade Bath, BA, Caroline L Ng, PhD, Annie N Cowell, MD, Elizabeth A Winzeler, PhD, David A Fidock, PhD, Mark Baker, PhD, Jörg J Möhrle, PhD, Rob Hooft van Huijsduijnen, PhD, Nathalie Gobeau, PhD, Nada Araeipour, MA, Nicole Andenmatten, PhD, Thomas Rückle, PhD, Stephan Duparc, MD  The Lancet Infectious Diseases  Volume 18, Issue 8, Pages 874-883 (August 2018) DOI: 10.1016/S1473-3099(18)30309-8 Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure 1 Trial design and patients ITT=intention-to-treat. The Lancet Infectious Diseases 2018 18, 874-883DOI: (10.1016/S1473-3099(18)30309-8) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.